Welcome to LookChem.com Sign In|Join Free
  • or
3-Carboxy-alpha,alpha-difluorotoluene and 3-Carboxybenzal fluoride are both organic chemicals that contain a carboxylic acid group and a benzene ring. The 3-Carboxy-alpha,alpha-difluorotoluene molecule has a 3-carboxy group and two fluorine atoms attached to the benzene ring, while 3-Carboxybenzal fluoride has a 3-carboxy group and a fluorine atom attached to the benzene ring. Their structural similarity to aromatic compounds makes them valuable building blocks for the creation of complex organic molecules.

55805-20-4

Post Buying Request

55805-20-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55805-20-4 Usage

Uses

Used in Pharmaceutical Industry:
3-Carboxy-alpha,alpha-difluorotoluene and 3-Carboxybenzal fluoride are used as intermediates in the synthesis of pharmaceuticals for their versatile reactivity and ability to participate in a variety of chemical reactions.
Used in Agrochemical Industry:
3-Carboxy-alpha,alpha-difluorotoluene and 3-Carboxybenzal fluoride are used as intermediates in the synthesis of agrochemicals for their versatile reactivity and ability to participate in a variety of chemical reactions.
Used in Fine Chemicals Industry:
3-Carboxy-alpha,alpha-difluorotoluene and 3-Carboxybenzal fluoride are used as intermediates in the synthesis of other fine chemicals for their versatile reactivity and ability to participate in a variety of chemical reactions.

Check Digit Verification of cas no

The CAS Registry Mumber 55805-20-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,8,0 and 5 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 55805-20:
(7*5)+(6*5)+(5*8)+(4*0)+(3*5)+(2*2)+(1*0)=124
124 % 10 = 4
So 55805-20-4 is a valid CAS Registry Number.

55805-20-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(Difluoromethyl)benzoic acid

1.2 Other means of identification

Product number -
Other names 3-Carboxybenzal fluoride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55805-20-4 SDS

55805-20-4Relevant academic research and scientific papers

Transition-metal-free C-H oxidative activation: Persulfate-promoted selective benzylic mono- and difluorination

Ma, Jing-Jing,Yi, Wen-Bin,Lu, Guo-Ping,Cai, Chun

supporting information, p. 2890 - 2894 (2015/04/27)

An operationally simple and selective method for the direct conversion of benzylic C-H to C-F to obtain mono- and difluoromethylated arenes using Selectfluor as a fluorine source is developed. Persulfate can be used to selectively activate benzylic hydrogen atoms toward C-F bond formation without the aid of transition metal catalysts.

TETRAZOLINONE COMPOUND AND USE THEREOF

-

Paragraph 0862, (2015/11/16)

The compound represented by formula (1): wherein R4 and R5 each represents a hydrogen atom, a halogen atom, or a C1-C3 alkyl group; R6 represents a C1-C4 alkyl group, a C3-C6 cycloalkyl group, or the like; R7, R8, and R9 each represents a hydrogen atom, a halogen atom, or the like; R10 represents a C1-C3 alkyl group, or the like; R13 represents a C1-C3 alkyl group, or the like; and Q represents a phenyl group, or the like; has an excellent control effect on pests.

BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS

-

Paragraph 0175; 0177, (2014/09/29)

The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 55805-20-4